Alkem Laboratories Limited
ALKEM
Hisse Senetlerindeki Sıralama
#2887
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Hisse Fiyatı
$52.72
Piyasa Değeri
$6.30B
Değişim (1 gün)
-4.47%
Değişim (1 yıl)
-16.34%
Ülke
IN
Ticaret Alkem Laboratories Limited (ALKEM)
Kategori
Healthcare
Alkem Laboratories Limited (ALKEM) için gelir
Jun 2026 itibarıyla gelir TTM: $1.66B
Alkem Laboratories Limited şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $1.66B'dir. 2025 yılında şirketin geliri $1.50B önceki yıla göre artış 2024 yılındaki $1.49B gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Alkem Laboratories Limited için 2010 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değiştir |
|---|---|---|
| 2026 (TTM) | $1.66B | 11.17% |
| 2025 | $1.50B | 0.36% |
| 2024 | $1.49B | 7.16% |
| 2023 | $1.39B | 0.53% |
| 2022 | $1.38B | 16.14% |
| 2021 | $1.19B | 9.65% |
| 2020 | $1.09B | 3.92% |
| 2019 | $1.05B | 8.08% |
| 2018 | $968.16M | 11.79% |
| 2017 | $866.05M | 17.92% |
| 2016 | $734.41M | 23.43% |
| 2015 | $595.01M | 15.94% |
| 2014 | $513.19M | 22.45% |
| 2013 | $419.09M | 10.73% |
| 2012 | $378.47M | 2.07% |
| 2011 | $370.79M | 23.92% |
| 2010 | $299.23M | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 297.25% |
IN
|
